Experimental models of liver fibrosis-Reference-Cited by-同舟云学术

Experimental models of liver fibrosis

Published:2015-06-06 Issue:5 Volume:90 Page:1025-1048
ISSN:0340-5761
Container-title:Archives of Toxicology
language:en
Short-container-title:Arch Toxicol

Author:

Crespo Yanguas Sara,Cogliati Bruno,Willebrords Joost,Maes Michaël,Colle Isabelle,van den Bossche Bert,de Oliveira Claudia Pinto Marques Souza,Andraus Wellington,Alves Venâncio Avancini,Leclercq Isabelle,Vinken Mathieu

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Toxicology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00204-015-1543-4.pdf

Reference237 articles.

1. Abdel-Aziz G, Lebeau G, Rescan PY et al (1990) Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am J Pathol 137(6):1333–1342

2. Abergel A, Sapin V, Dif N et al (2006) Growth arrest and decrease of alpha-SMA and type I collagen expression by palmitic acid in the rat hepatic stellate cell line PAV-1. Dig Dis Sci 51(5):986–995

3. Abu-Absi SF, Hansen LK, Hu WS (2004) Three-dimensional co-culture of hepatocytes and stellate cells. Cytotechnology 45(3):125–140

4. Anstee QM, Goldin RD (2006) Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 87(1):1–16

5. Aparicio-Bautista DI, Pérez-Carreón JI, Gutiérrez-Nájera N et al (2013) Comparative proteomic analysis of thiol proteins in the liver after oxidative stress induced by diethylnitrosamine. Biochim Biophys Acta 1834(12):2528–2538

Cited by 264 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gentiana decoction inhibits liver fibrosis and the activation of hepatic stellate cells via upregulating the expression of Parkin;Fitoterapia;2024-10

2. STA-9090 in combination with a statin exerts enhanced protective effects in rats fed a high-fat diet and exposed to diethylnitrosamine and thioacetamide;Frontiers in Pharmacology;2024-09-04

3. A novel experimental mouse model of diabetic nonalcoholic steatohepatitis: A critical role for acid-sensitive Ion Channel 1a;Biomedicine & Pharmacotherapy;2024-09

4. Resveratrol treatment ameliorates hepatic damage via the TGF- β /SMAD signaling pathway in a phenobarbital/CCl4-induced hepatic fibrosis model;IRAN J BASIC MED SCI;2024

5. Transcription factor YY1 accelerates hepatic fibrosis development by activating NLRP3 inflammasome-mediated pyroptosis;HISTOL HISTOPATHOL;2024